Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 879585, 12 pages
http://dx.doi.org/10.1093/ecam/nep042
Original Article

Bioactivity of the Murex Homeopathic Remedy and of Extracts from an Australian Muricid Mollusc against Human Cancer Cells

School of Biological Sciences, Flinders University, GPO Box 2100, Adelaide, 5001, Australia

Received 9 December 2008; Accepted 7 April 2009

Copyright © 2011 Kirsten Benkendorff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Cooper, “Drug discovery, CAM and natural products,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 215–217, 2004. View at Google Scholar
  2. E. L. Cooper, “Commentary on traditional and modern biomedical prospecting: part II—the benefits by Werner E.G. Müller, Heinz C. Schröder, Matthias Wiens, Sanja Perović-Ottstadt, Renato Batel and Isabel M. Müller Anti-protozoa and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin by P. Roch, A. Beschin and E. Bernard,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 207–209, 2004. View at Google Scholar
  3. S. Grabley and R. Thiericke, Drug Discovery from Nature, Springer, Berlin, Germany, 1999.
  4. T. L. Simmons, E. Andrianasolo, K. McPhail, P. Flatt, and W. H. Gerwick, “Marine natural products as anticancer drugs,” Molecular Cancer Therapeutics, vol. 4, no. 2, pp. 333–342, 2005. View at Google Scholar
  5. G. Faircloth and C. Cuevas, “Kahalalide F and ES285: potent anticancer agents from marine molluscs,” in Molluscs: From Chemo-Ecological Study to Biotechnological Application, C. Cimino and M. Gavagnin, Eds., pp. 363–379, Springer, Berlin, Germany, 2006. View at Google Scholar
  6. D. Newman and G. Cragg, “Marine natural products and related compounds in clinical and advanced preclinical trials,” Journal of Natural Products, vol. 67, pp. 1216–1238, 2004. View at Google Scholar
  7. J. T. Baker, “Tyrian purple: an ancient dye, a modern problem,” Endeavour, vol. 33, no. 118, pp. 11–17, 1974. View at Google Scholar
  8. K. Benkendorff, J. B. Bremner, and A. R. Davis, “Tyrian purple precursors in the egg masses of the Australian muricid, Dicathais orbita: a possible defensive role,” Journal of Chemical Ecology, vol. 26, no. 4, pp. 1037–1050, 2000. View at Publisher · View at Google Scholar
  9. C. J. Cooksey, “Tyrian purple: 6,6-dibromoindigo and related compounds,” Molecules, vol. 6, no. 9, pp. 736–769, 2001. View at Google Scholar
  10. J. T. Baker and C. C. Duke, “Isolation of choline and choline ester salts of tyrindoxyl sulphate from the marine molluscs Dicathais orbita and Mancinella keineri,” Tetrahedron Letters, vol. 15, pp. 1233–1234, 1976. View at Google Scholar
  11. C. Westley, K. Vine, and K. Benkendorff, “A proposed functional role for indole derivatives in reproduction and defense of the Muricidae Neogastropoda:Mollusca,” in Indirubin, the Red Shade of Indigo, L. Meijer, N. Guyard, A. L. Skaltsounis, and G. Eisenbrand, Eds., pp. 31–44, Life in Progress, Roscoff, France, 2006. View at Google Scholar
  12. K. Benkendorff, J. B. Bremner, and A. R. Davis, “Indole derivatives from the egg masses of muricid molluscs,” Molecules, vol. 6, no. 2, pp. 70–78, 2001. View at Google Scholar
  13. H. Palma, J. Paredes, and E. Cristi, “6,6'-dibromoindigotin en capsulas de embriones di Concholepas concholepas (Bruguiere, 1789),” Medio Ambiente, vol. 11, pp. 93–95, 1999. View at Google Scholar
  14. K. Vine, J. Locke, M. Ranson, K. Benkendorff, S. Pyne, and J. Bremner, “In vitro cytotoxicity evaluation of some substituted isatin derivatives,” Bioorganic & Medicinal Chemistry, vol. 15, pp. 931–938, 2007. View at Google Scholar
  15. C. Westley and K. Benkendorff, “Sex-specific Tyrian purple genesis: precursor and pigment distribution in the reproductive system of the marine mollusc, Dicathais orbita,” Journal of Chemical Ecology, vol. 34, no. 1, pp. 44–56, 2008. View at Publisher · View at Google Scholar · View at PubMed
  16. L. Meijer, A.-L. Skaltsounis, and A.-L. Skaltsounis, “GSK-3-selective inhibitors derived from tyrian purple indirubins,” Chemistry and Biology, vol. 10, no. 12, pp. 1255–1266, 2003. View at Publisher · View at Google Scholar
  17. S. Leclerc, M. Garnier, and M. Garnier, “Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?” Journal of Biological Chemistry, vol. 276, no. 1, pp. 251–260, 2001. View at Publisher · View at Google Scholar · View at PubMed
  18. S. Nam, R. Buettner, and R. Buettner, “Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 17, pp. 5998–6003, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. G. Sethi, K. Ahn, S. K. Sandur, X. Lin, M. M. Chaturvedi, and B. B. Aggarwal, “Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-κB signaling pathway,” Journal of Biological Chemistry, vol. 281, no. 33, pp. 23425–23435, 2006. View at Publisher · View at Google Scholar · View at PubMed
  20. S.-A. Kim, Y.-C. Kim, S.-W. Kim, S.-H. Lee, J.-J. Min, S.-G. Ahn, and J.-H. Yoon, “Antitumor activity of novel indirubin derivatives in rat tumor model,” Clinical Cancer Research, vol. 13, no. 1, pp. 253–259, 2007. View at Publisher · View at Google Scholar · View at PubMed
  21. H.-H. Fiebig and J. Schuler, “In vivo antitumor activity of 5-methyl-indirubin,” in Indirubin, the Red Shade of Indigo, L. Meijer, N. Guyard, A. L. Skaltsounis, and G. Eisenbrand, Eds., pp. 209–213, Life in Progress, Roscoff, France, 2006. View at Google Scholar
  22. R. Hoessel, S. Leclerc, and S. Leclerc, “Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases,” Nature Cell Biology, vol. 1, no. 1, pp. 60–67, 1999. View at Google Scholar
  23. C. Dunham, “Murex purpurea,” American Homeopathic Review, vol. 4, pp. 306–315, 1864. View at Google Scholar
  24. B. J. Murex, Homeopathic Materia Medica, Winhomeo Books, 9th edition, 1999.
  25. S. Cazalet, “Materia Medica: Repertorium Homepathicum (Reversed Kent's Repertory),” May 2009, http://www.homeoint.org/hidb/kent/index.htm.
  26. S. Straus, “Complementary and alternative medicine: challenges and opportunities for pharmacology and therapeutic research,” Pharmacologist, vol. 42, pp. 74–76, 2000. View at Google Scholar
  27. G. Pitari, “Scientific research in homeopathic medicine: validation, methodology and perspectives,” Evidence-Based Complementary and Alternative Medicine, vol. 4, no. 2, pp. 271–273, 2007. View at Publisher · View at Google Scholar
  28. N. Bhattacharjee, S. Pathak, and A. R. Khuda-Bukhsh, “Amelioration of carinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200,” Evidence-Based Complementary and Alternative Medicine, vol. 6, pp. 65–75, 2007. View at Google Scholar
  29. L. Meijer, J. Shearer, K. Bettayeb, and Y. Ferandin, “Diversity of intracellular mechanisms underlying the anti-tumour properties of indirubins,” in Indirubin, the Red Shade of Indigo, L. Meijer, N. Guyard, A. L. Skaltsounis, and G. Eisenbrand, Eds., pp. 235–246, Life in Progress, Roscoff, France, 2006. View at Google Scholar
  30. B. F. Phillips, N. A. Campbell, and B. R. Wilson, “A multivariate study of geographic variation in the whelk Dicathais,” Journal of Experimental Marine Biology and Ecology, vol. 11, no. 1, pp. 27–69, 1973. View at Google Scholar
  31. J. Baker and C. Duke, “Isolation from the hypobranchial glands of marine molluscs of 6-bromo-2,2-dimethylthioindolin-3-one and 6-bromo-2-methylthioindoleninone as alternative precursors to tyrian purple,” Australian Journal of Chemistry, vol. 26, pp. 2153–2157, 1973. View at Google Scholar
  32. A. H. Cory, T. C. Owen, J. A. Barltrop, and J. G. Cory, “Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture,” Cancer Communications, vol. 3, no. 7, pp. 207–212, 1991. View at Google Scholar
  33. D. D. Baker, M. Chu, U. Oza, and V. Rajgarhia, “The value of natural products to future pharmaceutical discovery,” Natural Product Reports, vol. 24, no. 6, pp. 1225–1244, 2007. View at Publisher · View at Google Scholar · View at PubMed
  34. J. T. Nguyen and J. A. Wells, “Direct activation of the apoptosis machinery as a mechanism to target cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7533–7538, 2003. View at Publisher · View at Google Scholar · View at PubMed
  35. S. H. Woodcock and K. Benkendorff, “The impact of diet on the growth and proximate composition of juvenile whelks, Dicathais orbita (Gastropoda: Mollusca),” Aquaculture, vol. 276, no. 1–4, pp. 162–170, 2008. View at Publisher · View at Google Scholar
  36. M. Roseghini, C. Severini, E. Falconieri, and V. Erspamer, “Choline esters and biogenic amines in the hypobranchial gland of 55 molluscan species of the neogastropod Muricidae Superfamily,” Toxicon, vol. 34, pp. 33–55, 1996. View at Google Scholar
  37. C. Tomelleri, E. Milotti, C. Dalla Pellegrina et al., “A quantitative study on the growth variability of tumor cell clones in vitro,” Cell Proliferation, vol. 41, pp. 177–191, 2008. View at Google Scholar
  38. J. R. W. Masters, “Human cancer cell lines: fact and fantasy,” Nature Reviews Molecular Cell Biology, vol. 1, no. 3, pp. 233–236, 2000. View at Google Scholar
  39. J. M. Brown and B. G. Wouters, “Apoptosis, p53, and tumor cell sensitivity to anticancer agents,” Cancer Research, vol. 59, no. 7, pp. 1391–1399, 1999. View at Google Scholar
  40. J. Baker and M. Sutherland, “Pigments of marine animals VIII. Precursors of 6,6-dibromoindigotin (tyrian purple) from the mollusc Dicathais orbita (Gmelin),” Tetrahedron Letters, vol. 1, pp. 43–46, 1968. View at Google Scholar
  41. S. Aabel, S. Fossheim, and F. Rise, “Nuclear magnetic resonance (NMR) studies of homeopathic solutions,” British Homeopathic Journal, vol. 90, no. 1, pp. 14–20, 2001. View at Google Scholar
  42. P. Fisher, “Homeopathy: a multifaceted scientific renaissance,” Journal of Alternative and Complementary Medicine, vol. 7, no. 2, pp. 123–125, 2001. View at Google Scholar